Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial for Cervicothoracic Sympathetic Chain Block Against Placebo Saline Injection Evaluation for Post COVID Condition: the CeASE RCT

NCT07468604 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT07468604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07468604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial for Cervicothoracic Sympathetic Chain Block Against Placebo Saline Injection Evaluation for Post COVID Condition: the CeASE RCT
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Recruiting
Start date
May 19, 2026
Completion date
September 1, 2027
Enrollment
78 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autonomic dysfunction